共 24 条
Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension
被引:27
作者:
Fujii, Aya
Nakano, Daisuke
Katsuragi, Miyuki
Ohkita, Mamoru
Takaoka, Masanori
Ohno, Yukihiro
Matsumura, Yasuo
机构:
[1] Osaka Univ Pharmaceut Sci, Dept Pharmacol, Takatsuki, Osaka 5691094, Japan
[2] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan
关键词:
NADPH oxidase;
gp91phox;
deoxycorticosterone acetate (DOCA)-salt hypertension;
superoxide;
D O I:
10.1016/j.ejphar.2006.09.039
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
NADPH oxidase plays an important role in vascular oxidative stress in hypertensive diseases. We evaluated whether NADPH oxidase-dependent superoxide (02) production is involved in the deoxycorticosterone acetate (DOCA)-salt-induced hypertension, using mice which are genetically deficient in gp91 phox, an NADPH oxidase subunit protein (gp91(-/-) mice). Two weeks after the DOCA-salt treatment, systolic blood pressure was significantly elevated in wild-type mice, but not in gp91(-/-) mice. After a 5-week treatment period, wild-type mice developed high blood pressure, with a systolic blood pressure of 127 +/- 3 mm Hg, compared with 107 +/- 4 mm Hg in gp91(-/-) mice. Aortic O-2(-) production in wild-type DOCA-salt-treated mice was significantly higher than that in wild-type sham mice, whereas there were no significant differences in aortic 02 production between gp91(-/-) DOCA-salt-treated and sham mice. These findings suggest that vascular O-2(-) overproduction via gp91 phox-containing NADPH oxidase is one of the crucial factors in the development of DOCA-salt-induced hypertension. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 134
页数:4
相关论文